139 related articles for article (PubMed ID: 15668264)
1. Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease.
Garipidou V; Vakalopoulou S; Zafiriadou E; Kaloutsi V; Tziomalos K; Perifanis V
Ann Oncol; 2005 Mar; 16(3):514-5. PubMed ID: 15668264
[No Abstract] [Full Text] [Related]
2. [Sarcoidosis-like reaction after treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in a patient with Hodgkin's lymphoma].
Torrent A; Navarro JT; Andreo FC; Ribera JM
Med Clin (Barc); 2013 Aug; 141(3):134-5. PubMed ID: 23332624
[No Abstract] [Full Text] [Related]
3. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's lymphoma: better outcomes with fewer drugs?
Casasnovas O; Coiffier B
Lancet; 2015 Apr; 385(9976):1371-3. PubMed ID: 25539731
[No Abstract] [Full Text] [Related]
5. Presentation of Hodgkin's lymphoma with Ophelia syndrome.
Olmos D; Rueda A; Jurado JM; Alba E
J Clin Oncol; 2007 May; 25(13):1802-3. PubMed ID: 17470872
[No Abstract] [Full Text] [Related]
6. Risk of pulmonary toxicity of bleomycin and filgrastim.
Laprise-Lachance M; Lemieux P; Grégoire JP
J Oncol Pharm Pract; 2019 Oct; 25(7):1638-1644. PubMed ID: 30319063
[TBL] [Abstract][Full Text] [Related]
7. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
Ahmed BM; Al-Zakwani IS
J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
[TBL] [Abstract][Full Text] [Related]
8. Superior vena cava syndrome caused by Hodgkin's lymphoma in an adolescent girl.
Rizvi I; Zaman S; Zaidi N; Ashraf SM; Kumar A; Gupta A; Ahmad M
BMJ Case Rep; 2012 Feb; 2012():. PubMed ID: 22665460
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of survival in Hodgkin's lymphoma.
Canellos GP; Niedzwiecki D; Johnson JL
N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
[No Abstract] [Full Text] [Related]
10. Cutaneous flagellate pigmentation by bleomycin.
Spedini P; Bergonzi C; Morandi S
Haematologica; 2000 Aug; 85(8):870. PubMed ID: 10942936
[No Abstract] [Full Text] [Related]
11. Renal Hodgkin's disease.
Pilatrino C; Cataldi A; Guerrasio A; Saglio G
Br J Haematol; 2002 Mar; 116(4):732. PubMed ID: 11886375
[No Abstract] [Full Text] [Related]
12. Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data?
Basaran G; Agaoglu F; Basaran M
J Clin Oncol; 2010 Sep; 28(27):e485-6; author reply e487. PubMed ID: 20606082
[No Abstract] [Full Text] [Related]
13. Comparison of outcomes in studies of advanced Hodgkin's lymphoma.
Johnson PW; Radford JA; Cullen MH; Sydes MR; Stenning SP; Hancock BW
J Clin Oncol; 2006 Jul; 24(20):3309; author reply 3309-10. PubMed ID: 16829655
[No Abstract] [Full Text] [Related]
14. [Primary pulmonary Hodgkin's disease].
Hosoi K; Chikuie N; Min KY; Satoh T; Tokumine Y; Ishikawa K; Maeda H; Ueda K; Inoue M
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1399-401. PubMed ID: 16097597
[No Abstract] [Full Text] [Related]
15. Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?
Abou Yehia Z; Mikhaeel GN; Smith G; Pinnix CC; Milgrom SA; Tang C; Jiang W; Fanale MA; Oki Y; Shank JH; Horace T; Reddy J; Akhtari M; Gunther JR; Suki T; Allen PK; Turner S; Mawlawi O; Dabaja BS
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):951-958. PubMed ID: 27742539
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Busia A; Laffranchi A; Viviani S; Bonfante V; Villani F
Anticancer Res; 2010 Oct; 30(10):4381-7. PubMed ID: 21036768
[TBL] [Abstract][Full Text] [Related]
17. [Hodgkin lymphoma--ABVD regimen].
Nagai H
Nihon Rinsho; 2015 Feb; 73 Suppl 2():642-5. PubMed ID: 25831839
[No Abstract] [Full Text] [Related]
18. Uncommon presentations of Hodgkin's disease. Case 3. Hodgkin's disease: rectal presentation.
Simpson L; Taylor S; Piotrowski A
J Clin Oncol; 2004 Jan; 22(1):196-8. PubMed ID: 14701784
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Harker WG; Kushlan P; Rosenberg SA
Ann Intern Med; 1984 Oct; 101(4):440-6. PubMed ID: 6206757
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
